138 related articles for article (PubMed ID: 8684714)
1. Antipsychotics and neuropeptides: the atypical profile of CI-943 and its relationship to neurotensin.
Liégeois JF; Bonaventure P; Delarge J; Damas J
Neurosci Biobehav Rev; 1995; 19(4):519-31. PubMed ID: 8684714
[TBL] [Abstract][Full Text] [Related]
2. Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations.
Levant B; Bissette G; Davis MD; Heffner TG; Nemeroff CB
Synapse; 1991 Nov; 9(3):225-30. PubMed ID: 1685600
[TBL] [Abstract][Full Text] [Related]
3. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
Kinkead B; Nemeroff CB
J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
[TBL] [Abstract][Full Text] [Related]
4. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.
Binder EB; Kinkead B; Owens MJ; Kilts CD; Nemeroff CB
J Neurosci; 2001 Jan; 21(2):601-8. PubMed ID: 11160439
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment.
Myers B; Levant B; Bissette G; Nemeroff CB
Brain Res; 1992 Mar; 575(2):325-8. PubMed ID: 1349254
[TBL] [Abstract][Full Text] [Related]
7. Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.
Holtom PE; Needham PL; Bennett GW; Aspley S
Br J Pharmacol; 2000 Nov; 131(5):990-6. PubMed ID: 11053221
[TBL] [Abstract][Full Text] [Related]
8. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei.
Kilts CD; Anderson CM; Bissette G; Ely TD; Nemeroff CB
Biochem Pharmacol; 1988 Apr; 37(8):1547-54. PubMed ID: 3358784
[TBL] [Abstract][Full Text] [Related]
10. Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs.
Merchant KM; Dobie DJ; Dorsa DM
Ann N Y Acad Sci; 1992; 668():54-69. PubMed ID: 1361120
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of the effect of antipsychotic drug treatment on neurotensin concentrations in the rat brain.
Kinkead B; Owens MJ; Nemeroff CB
Synapse; 1995 Jul; 20(3):244-8. PubMed ID: 7570356
[TBL] [Abstract][Full Text] [Related]
12. Do neuropeptide systems mediate some of the effects of antipsychotic drugs?
Bissette G; Nemeroff CB
Prog Clin Biol Res; 1985; 192():349-53. PubMed ID: 2867552
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
Stowe ZN; Bissette G; Nemeroff CB
Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
[TBL] [Abstract][Full Text] [Related]
14. Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugs.
Levant B; Bissette G; Widerlöv E; Nemeroff CB
Regul Pept; 1991 Feb; 32(2):193-201. PubMed ID: 1674615
[TBL] [Abstract][Full Text] [Related]
15. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
Pugsley TA; Coughenour LL; Myers SL; Shih YH; Courtland GG; Berghoff W; Stewart SF
J Pharmacol Exp Ther; 1989 Oct; 251(1):113-22. PubMed ID: 2571713
[TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
Radke JM; Owens MJ; Ritchie JC; Nemeroff CB
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11462-4. PubMed ID: 9736759
[TBL] [Abstract][Full Text] [Related]
17. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
Ma J; Ye N; Cohen BM
Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
Kinkead B; Shahid S; Owens MJ; Nemeroff CB
J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
[TBL] [Abstract][Full Text] [Related]
19. Does neurotensin mediate the effects of antipsychotic drugs?
Kinkead B; Binder EB; Nemeroff CB
Biol Psychiatry; 1999 Aug; 46(3):340-51. PubMed ID: 10435199
[TBL] [Abstract][Full Text] [Related]
20. Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
Levant B; Nemeroff CB
J Pharmacol Exp Ther; 1990 Jul; 254(1):330-5. PubMed ID: 1973198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
